Recurrent Pneumonia due to Persistent Chiamydia Pneumoniae Infection

スポンサーリンク

概要

• 論文の詳細を見る

• Two cases of recurrent pneumonia due to Chlamydia pneumoniae are described. C. pneumoniae was continuously detected from the nasopharynx in both patients by the polymerase chain reaction and/or culture even with appropriate antibiotic therapy during the first episode. After eradication of C. pneumoniae with long-term macrolide therapy, the respiratory symptoms of both patients completely disappeared and no relapse was observed. These data indicate that new treatment strategies may be necessary to eradicate the organism in patients prone to persistent infection.(Internal Medicine 41: 30-33, 2002)

• 社団法人 日本内科学会の論文

著者

• Matsushima Toshiharu

  昭和大学 医学部臨床感染症学

• Matsushima Toshiharu

  東北大学加齢医学研究所 抗感染症薬開発研究部門

• Niki Yoshihito

  昭和大学 医学部臨床感染症学

• Niki Y

  Showa University School Of Medicine Department Of Clinical Infectious Diseases

• Yoshihito Niki

  Department Of Respiratory And Internal Medicine Kawasaki Medical School

• Niki Yoshihito

  Division Of Respiratory Diseases Department Of Medicine Kawasaki Medical School

• Kobashi Yoshihiro

  川崎医科大学 医学部内科学(呼吸)

• Niki Yoshihito

  Showa University School Of Medicine Department Of Clinical Infectious Diseases

• Kubota Y

  Division Of Respiratory Diseases Department Of Medicine Kawasaki Medical School

• Yoshida Kouichirou

  昭和大学 医学部臨床感染症学

• MIYASHITA Naoyuki

  Division of Respiratory Diseases, Department of Medicine, Kawasaki Medical School

• MATSUSHIMA Toshiharu

  Division of Respiratory Diseases, Department of Medicine, Kawasaki Medical School

• Manabe Takao

  大阪市立総合医療センター

• Matsushima T

  Division Of Respiratory Diseases Department Of Medicine Kurashiki Daiichi Hospital

• Hara Hiroki

  Junpukai Kurashiki Daiichi Hospital

• MATSUSHIMA Toshiharu

  Junpukai Kurashiki Daiichi Hospital

• FUKANO Hiroshi

  Division of Respiratory Diseases, Department of Medicine, Kawasaki Medical School

• HARA Hiroki

  Department of Medicine, Kurashiki Daiichi Hospital

• YOSHIDA Koichiro

  Division of Respiratory Diseases, Department of Medicine, Kawasaki Medical School

• Miyashita Naoyuki

  Division Of Respiratory Diseases Department Of Internal Medicine

• Fukano Hiroshi

  Division Of Respiratory Diseases Department Of Medicine Kawasaki Medical School

• Matsushima Toshiharu

  Division Of Arespiratory Diseases Department Of Medicine Kawasaki Medical School

• Matsushima Toshiharu

  The Division Of Respiratory Diseases Department Of Medicine Kawasaki Medical School

• Takashima M

  Japan Collection Of Microorganisms Riken (the Institute Of Physical And Chemical Research)

• Yoshida Koichiro

  Department Of Clinical Infectious Diseases School Of Medicine Showa University

• Yoshida Koichiro

  Division Of Respiratory Diseases Department Of Medicine Kawasaki Medical School

• Manabe T

  Osaka City General Hospital

• Miyashita Naoyuki

  Department Of Respiratory Diseases Kawasaki Medical School

• Miyashita Naoyuki

  Department Of Respiratory Medicine Kawasaki Medical School

• Hara Hiroki

  Department Of Civil Engineering Graduate School Of Engineering Kobe University

• Kobashi Yoshihiro

  The Division Of Respiratory Diseases Department Of Medicine Kawasaki Medical School Kawasaki Hospita

• Fukano Hiroshi

  Department Of Internal Medicine Center For Respiratory Disease Kurashiki Daiichi Hospital

• Niki Yoshihito

  Division Of Clinical Infectious Diseases Department Of Internal Medicine Showa University School Of Medicine

• Yoshida Kouichirou

  Division Of The Respiratory Diseases The Department Of Medicine Kawasaki Medical School

• Yoshida Koichiro

  Division Of Clinical Infectious Diseases Department Of Internal Medicine Showa University School Of Medicine

• Miyashita Naoyuki

  Division of Respiratory Disease, Department of Medicine, Kawasaki Medical School, Japan

関連論文

• マイコプラズマ肺炎 (特集 呼吸器感染症2010--新たな脅威と必要な新知識) -- (一般診療で見逃してはならないもの)
• 呼吸器感染症に対する levofloxacin 500mg 1日1回投与の臨床効果
• 急性気管支炎および慢性呼吸器病変の二次感染に対する azithromycin 単回投与製剤の多施設共同非盲験非対照試験
• 2004年に全国77施設から分離された臨床分離株18,639株の各種抗菌薬に対する感受性サーベイランス
• 呼吸器感染症に対する sitafloxacin の一般臨床試験
• 市中肺炎に対する sitafloxacin と tosufloxacin の第III相二重盲検比較試験
• 呼吸器感染症患者を対象とした garenoxacin の第III相一般臨床試験
• 慢性呼吸器病変の二次感染患者を対象とした garenoxacin の臨床第III相試験 : PK/PD試験
• 細菌性肺炎を対象とした garenoxacin の臨床第III相比較試験
• 小児細菌感染症に対する ceftriaxone 1日1回投与に関するアンケート調査
• 呼吸器感染症患者分離菌の薬剤感受性について : 2004年
• ニューキノロン (特集 上手な抗菌薬の使い方) -- (各種抗菌薬の特徴と適正使用)
• (1→3)-β-D-グルカン測定の問題点と進歩
• 感染(3)理学療法士が知っておくべき感染知識(応用・復習編)
• クリプトコックス症 (特集 糖尿病と真菌症--臨床免疫と分子生物学的アプローチ) -- (主な深在性真菌症の病態,診断,治療--診断・治療ガイドライン2007を踏まえて)
• 感染症の血清診断 肺真菌症の血清診断 (呼吸器疾患の臨床検査up to date) -- (血液検査)
• 在宅感染症対策 入院への切り替え時期を誤らないこと--在宅ケアにおける効果的な抗菌療法
• 成人市中肺炎と抗菌薬 (特集 市中肺炎--症例と指針で学ぶガイドラインの実際)
• 市中肺炎診療ガイドラインの課題 (特集 市中肺炎治療とガイドライン) -- (市中肺炎の診療ガイドライン)
• ガイドラインの読み方--国内の市中肺炎ガイドラインの比較と効率的な使い方 (特集 臨床医が知っておくべき抗菌薬の使い方)
• 真菌感染症 (特集 感染症の新しい検査法と最近のトピックス)
• 深在性真菌症と抗真菌薬の適正使用
• Industrial Info. アムホテリシンB リポソーム製剤
• レスピラトリーキノロン (特集 抗菌薬の特性を活かして上手に使うコツ) -- (臨床で活かす各系統の抗菌薬の特性)
• 改良アルカリ前処理法を用いた(1→3)-β-D-グルカン測定法の臨床的有用性 : 従来法との比較
• 深在性真菌症患者に対する itraconazole 注射薬およびカプセル薬順次投与の有効性
• 肺アスペルギルス症の診断・治療とボリコナゾールの位置づけについて
• Bedside Teaching 重症真菌感染症の治療戦略
• インフルエンザ感染症 (患者さんの背景・病態で考える 薬の選び方・使い方のエッセンス) -- (感染症)
• 呼吸器感染症に対する sitafloxacin と levofloxacin の二重盲検比較試験
• 慢性閉塞性肺疾患症例の急性増悪に対するニューキノロン系抗菌薬とβ-ラクタム系抗菌薬の有用性
• 深在性真菌症 (特集 内科診療ガイドライン活用法) -- (感染症)
• ペニシリン耐性肺炎球菌による呼吸器感染症を対象とした garenoxacin の第III相一般臨床試験
• 肺アスペルギルス症に対する micafungin の臨床効果
• 深在性真菌症診断とβ-D-グルカン値測定
• 高齢者における抗菌薬の使い方 (特集 感染症の治療--抗菌薬を使いこなそう) -- (特殊な病態における抗菌薬の選択と使い方:注意を要する抗菌薬の使い方)
• 侵襲性真菌感染症の血清診断法 (あゆみ 深在性真菌症--新ガイドラインと最新知見)
• Comparison of chest X-ray findings and other parameters in acute exacerbation of chronic bronchitis in Japan and the West
• Seroprevalence of Antibodies to Chlamydia spp.in Human Immunodeficiency Virus-Infected Subjects in Japan
• Continuous Isolation and Characterization of Chlamydia pneumoniae from a Patient with Diffuse Panbronchiolitis
• Immunohistochemical Distribution of Epithelioid Cell, Myofibroblast, and Transforming Growth Factor-β1 in the Granuloma Caused by Mycobacterium avium intracellulare Complex Pulmonary Infection
• 肺真菌症への外科的治療の適応を考える (特集 呼吸器感染症に向かう臨床医の決断力--なぜこの治療薬でいくか)
• Evaluation of clinical dosage of gatifloxacin for respiratory tract infections in elderly patients based on pharmacokinetics/pharmacodynamics (PK/PD)
• Recurrent Pneumonia due to Persistent Chiamydia Pneumoniae Infection
• Influence of gatifloxacin, a new quinolone antibacterial, on pharmacokinetics of theophylline
• Lung Adenocarcinoma Required the Differentiation from Wegener Granulomatosis
• Prospective multicenter study of the causative organisms of community-acquired pneumonia in adults in Japan
• Community-acquired Chlamydia pneumoniae Pneumonia in Japan : A Prospective Multicenter Community-acquired Pneumonia Study
• Sibling cases of Mycobacterium avium complex disease associated with hematological disease
• Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates
• Infectious bulla of the lung caused by Mycobacterium intracellulare
• Hermansky-Pudlak Syndrome with Interstitial Pneumonia without Mutation of HSP1 Gene
• Multifocal Micronodular Pneumocyte Hyperplasia in a Man with Tuberous Sclerosis
• Chronic Necrotizing Pulmonary Aspergillosis Complicated by a Cavitary Lesion Caused by Pulmonary Mycobacterium-avium Complex Disease
• Pulmonary Mycobacterium Avium Disease with a Solitary Pulmonary Nodule Requiring Differentiation from Recurrence of Pulmonary Adenocarcinoma
• Thoracic actinomycosis with mainly pleural involvement
• Effect of pazufloxacin mesilate on the serum concentration of theophylline
• The 7.5-kb common plasmid is unrelated to the drug susceptiility of Chlamydia trachomatis
• A Nested PCR Assay to Detect DNA in Sera for the Diagnosis of Deep-Seated Trichosporonosis
• Serum KL-6 as a Possible Marker for Amiodarone-induced Pulmonary Toxicity
• Association of Chronic Infection of Chlamydia pneumoniae and Coronary Heart Disease in the Japanese
• Clinical Analysis of Patients with Pseudomonas aeruginosa Bacteremia
• Clinical features of immunocompromised and nonimmunocompromised patients with pulmonary tuberculosis
• In Vitro Susceptibility of 7.5-kb Common Plasmid-Free Chlamydia trachomatis Strains
• CD8^+ T Lymphocyte Counts as an Adjunctive Predictor of Cytomegalovirus Retinitis in Patients with Acquired Immunodeficiency Syndrome
• Clinical Analysis of Community-Acquired Pneumonia in the Elderly
• Role of the Cytomegalovirus (CMV)-Antigenemia Assay as a Predictive and Follow-Up Detection Tool for CMV Disease in AIDS Patients
• Intraspecies Diversity of Cryptococcus albidus Isolated from Humans as Revealed by Sequences of the Internal Transcribed Spacer Regions
• Phylogenetic and Taxonomic Heterogeneity of Cryptococcus humicolus by Analysis of the Sequences of the Internal Transcribed Spacer Regions and 18S rDNA, and the Phylogenetic Relationships of C.humicolus, C.curvatus, and the Genus Trichosporon
• Linezolid-resistant methicillin-resistant Staphylococcus aureus isolated after long-term, repeated use of linezolid
• Lung abscess and pleuritis caused by Lactobacillus rhamnosus in an immunocompetent patient
• Antifungal Pharmacodynamic Characteristics of Amphotericin B against Trichosporon asahii, Using Time-Kill Methodology
• Effects of Fluoroquinolones on Experimental Pneumonia Caused by Penicillin-Resistant Streptococcus pneumoniae in Mice
• KL-6 as a Possible Monitoring Marker for Hypersensitivity Pneumonitis
• 市中肺炎の治療にキノロンを第一選択としてよいか? (特集 内科診療における論点) -- (感染症)
• Pathological Analysis of the Cavitary Wall in Mycobacterium Avium Intracellulare Complex Pulmonary Infection
• 注射薬 pazufloxacin 1 回1,000mg 1日2回投与時の細菌性肺炎を対象とした臨床第III相試験
• 肺炎の治療--最近の進展 (特集 肺炎--その治療と予防)
• In Vitro and In Vivo Activities of Sparfloxacin and Reference Drug Against Chlamydia pneumoniae
• Comparative Study of Mediastinal Emphysema as Determined by Etiology
• PK-PDから考えるレボフロキサシン500mg錠の意義 (特集 注目される抗菌薬・抗菌薬療法)
• Community-acquired Chlamydia pneumoniae Pneumonia in Japan : A Prospective Multicenter Community-acquired Pneumonia Study
• Recurrent Pneumonia due to Persistent Chiamydia Pneumoniae Infection
• The nationwide study of bacterial pathogens associated with urinary tract infections conducted by the Japanese Society of Chemotherapy
• Linezolid-resistant Staphylococcus aureus isolated from 2006 through 2008 at six hospitals in Japan
• 市中肺炎における levofloxacin 注射剤の ceftriaxone sodium を対照とした第III相比較試験
• 呼吸器感染症に対する levofloxacin 注射剤の臨床試験 (第II/III相験)
• Recurrence of Sarcoidosis Following Interferon Alpha Therapy for Chronic Hepatitis C
• Nonimmunocompromised Mouse Model of Penicillin-Resistant Streptococcus pneumoniae pneumonia
• Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy in 2008 : general view of the pathogens' antibacterial susceptibility
• Clinical viability of Fungitell, a new (1→3)-β-D-glucan measurement kit, for diagnosis of invasive fungal infection, and comparison with other kits available in Japan
• Q&A 肺炎診療におけるCRPとPCTの有用性を教えてください (特集 肺炎外来マネジメント)
• 血清診断は有用か? : β-D-グルカンの測定意義,対象は? (特集 外科救急領域における深在性真菌症対策 : カンジダ感染症を中心に : プラクティス・エビデンスの批判的吟味)
• Bedside Teaching 肺真菌症の血清診断
• 呼吸器感染症における新規抗菌薬の臨床評価法 (第二版)
• Efficacy and safety of moxifloxacin for community-acquired bacterial pneumonia based on pharmacokinetic analysis
• Two-way analysis for detecting factors affecting ventilator-associated pneumonia
• コリスチンの適正使用に関する指針
• Nationwide, multicenter survey on the efficacy and safety of piperacillin for adult community-acquired pneumonia in Japan
• Iliopsoas abscess caused by Aspergillus fumigatus complicated by pulmonary aspergillosis

もっと見る 閉じる

スポンサーリンク